Blastomycosis

8 clinical trials · Condition

Record	Firm	Date
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (NCT03059992)	Scynexis, Inc.	2017-04-01
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection (NCT00784368)	Janssen Pharmaceutical K.K.	2008-01-01
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection (NCT00001702)	National Cancer Institute (NCI)	1998-07-29
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis (NCT00004808)	National Center for Research Resources (NCRR)	1991-09-01
Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis (NCT00004811)	National Center for Research Resources (NCRR)	1985-03-01
A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis (NCT00002159)	Janssen, LP

Every clearance here is in the API, with alerts when new ones post.